Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Average Recommendation of “Hold” from Brokerages

Phibro Animal Health Corporation (NASDAQ:PAHC) has been assigned a consensus rating of “Hold” from the eight research firms that are covering the company, MarketBeat reports. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $31.40.

Several equities analysts have recently issued reports on PAHC shares. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Phibro Animal Health in a research report on Monday, December 8th. Morgan Stanley set a $34.00 target price on shares of Phibro Animal Health in a research note on Thursday, August 28th. Bank of America increased their price target on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a report on Friday, August 29th. Zacks Research upgraded shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 9th. Finally, JPMorgan Chase & Co. increased their target price on Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a research note on Friday, November 7th.

Insiders Place Their Bets

In other Phibro Animal Health news, CEO Jack Bendheim sold 38,303 shares of the company’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $45.29, for a total transaction of $1,734,742.87. Following the transaction, the chief executive officer owned 20,577 shares in the company, valued at approximately $931,932.33. This represents a 65.05% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last ninety days, insiders sold 147,824 shares of company stock valued at $6,385,720. 50.13% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PAHC. Cetera Investment Advisers grew its position in Phibro Animal Health by 18.9% in the 1st quarter. Cetera Investment Advisers now owns 11,550 shares of the company’s stock worth $247,000 after purchasing an additional 1,840 shares during the period. LPL Financial LLC boosted its stake in shares of Phibro Animal Health by 46.8% in the 1st quarter. LPL Financial LLC now owns 128,335 shares of the company’s stock worth $2,741,000 after buying an additional 40,889 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Phibro Animal Health by 0.4% in the first quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company’s stock worth $32,500,000 after acquiring an additional 6,784 shares during the period. National Bank of Canada FI purchased a new stake in Phibro Animal Health during the first quarter valued at $30,000. Finally, Invesco Ltd. lifted its holdings in Phibro Animal Health by 92.3% in the first quarter. Invesco Ltd. now owns 387,739 shares of the company’s stock valued at $8,282,000 after acquiring an additional 186,087 shares during the period. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Price Performance

PAHC stock opened at $40.15 on Monday. The company has a debt-to-equity ratio of 2.32, a quick ratio of 1.35 and a current ratio of 3.09. The firm has a 50 day moving average price of $41.23 and a 200-day moving average price of $34.66. Phibro Animal Health has a 52-week low of $16.16 and a 52-week high of $46.42. The firm has a market capitalization of $1.63 billion, a price-to-earnings ratio of 24.19, a PEG ratio of 1.14 and a beta of 0.77.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, beating analysts’ consensus estimates of $0.58 by $0.15. Phibro Animal Health had a return on equity of 36.26% and a net margin of 4.85%.The company had revenue of $363.89 million during the quarter, compared to analyst estimates of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. Equities research analysts forecast that Phibro Animal Health will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 17th. Investors of record on Wednesday, November 26th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.2%. The ex-dividend date is Wednesday, November 26th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 28.92%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.